Document:

Exhibit 10.37

                                 AMENDMENT NO. 1

     THIS AMENDMENT NO. 1 (the  "Amendment") is made and entered into as of July
11,  2001,  by and between  ROYAL GRIP,  INC.,  an Arizona  corporation  ("Royal
Grip"), and PRECISION FM JAPAN, LTD., a Japanese corporation ("Precision").

                                    RECITALS

     WHEREAS,  the parties  entered into an agreement,  dated July 12, 1991, for
the  exclusive  distributorship  of  Royal  Grip  Products  in the Far  East and
Southeast Asia (the "Agreement");

     WHEREAS,  the parties have determined to modify the Agreement in the manner
hereinafter set forth.

     NOW THEREFORE, the parties hereby agree as follows:

     Section 1.  AMENDMENT.  Section 3 is hereby amended in its entirety to read
as follows:

          3. TERM.  The initial term of this  Agreement  shall be for the period
beginning  the date  hereof,  such date  being the  "Effective  Date" and ending
January  31,  2002.  If, at the end of the  initial  term,  Precision  is not in
default of any of the terms  contained  herein,  it may renew the  Agreement for
additional, successive, two-year terms on the terms and conditions agreed.

     Section 2. CONTINUING VALIDITY. Except as amended herein, the provisions of
the  Agreement  shall  remain  unchanged  and in  full  force  and  effect.  All
references to the Agreement  hereafter  shall be deemed to mean and refer to the
Agreement, as amended by this Amendment.

     IN WITNESS WHEREOF, the parties have executed this Amendment as of the date
first above written.

                                          ROYAL GRIP, INC.

                                          By: /s/ Thomas A. Schneider
                                              ----------------------------------
                                              Name: Thomas A. Schneider
                                              Title: President

                                          PRECISION FM JAPAN, LTD.

                                          By: /s/ Sadami Nishioka
                                              ----------------------------------
                                              Name:  Sadami Nishioka
                                              Title: President<PAGE>   1
                                                                   EXHIBIT 10.76

                               AMENDMENT NO. 7 TO
                         LIMITED FORBEARANCE AGREEMENT

     AMENDMENT NO. 7 dated as of August 3, 2001 (the "Amendment"), to Limited
Forbearance Agreement dated as of January 11, 2000, as heretofore amended (the
"Forbearance Agreement") among THE KUSHNER-LOCKE COMPANY (the "Borrower"), its
subsidiaries (the "Guarantors", and together with the Borrower, the "Credit
Parties"), the Lenders party to the Credit Agreement defined below (the
"Lenders") and THE CHASE MANHATTAN BANK (formerly known as Chemical Bank), as
Agent and as Fronting Bank for the Lenders (the "Agent").

     The Borrower, the Guarantors, the Lenders and the Agent are parties to a
Credit, Security, Guaranty and Pledge Agreement, dated as of June 16, 1996, as
amended (the "Credit Agreement").

     As set forth in Section 1 of the Forbearance Agreement, Defaults and
Events of Default under the Credit Agreement have occurred and are continuing.
In order to allow the Borrower additional time to prepare for the proposed sale
of its film library and related accounts receivable and to explore various
restructuring options, the Borrower has requested that the Agent and the
Lenders amend the Forbearance Agreement to (i) extend the Lenders' agreement to
forebear from applying collections in respect of the Credit Parties'
receivables to repayment of the Loans, (ii) release an additional portion of
such collections to fund operating expenses of the Credit Parties and (iii)
make certain other modifications to the Forbearance Agreement.

     The Agent and the Lenders have agreed to the foregoing requests, all on
the terms and subject to the conditions hereinafter set forth.

     Accordingly, the parties hereby agree as follows:

     1.   Defined Terms. All capitalized terms not otherwise defined herein are
used as defined in the Forbearance Agreement.

     2.   Amendments to Forbearance Agreement. Subject to the satisfaction of
the condition precedent set forth in Section 3 hereof, the Forbearance
Agreement is hereby amended effective as of the Effective Date (as hereinafter
defined) as follows:

          (a)  The reference to "August 8, 2001" as the Stated Expiration Date
set forth in Section 2 of the Forbearance Agreement is hereby amended to be
"September 19, 2001."

          (b)  The Disbursement Schedule attached as Exhibit A to the
Forbearance Agreement is hereby replaced in its entirety with the Disbursement
Schedule attached as Exhibit A to this Amendment.

<PAGE>   2
     IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
duly executed by their duly authorized officers, all as of the date and year
first above written.

                                        BORROWER:

                                        THE KUSHNER-LOCKE COMPANY

                                        By: /s/ Donald Kushner
                                           -------------------------------------
                                           Name:  Donald Kushner
                                           Title: Co-CEO

                                        GUARANTORS:

                                        KL PRODUCTIONS, INC.
                                        POST AND PRODUCTION SERVICES, INC.
                                        TWILIGHT ENTERTAINMENT, INC.
                                        KLF GUILD CO.
                                        KLTV DEVELOPMENT CO.
                                        KUSHNER-LOCKE INTERNATIONAL, INC.
                                        KL INTERACTIVE MEDIA, INC.
                                        DAYTON WAY PICTURES III, INC.

                                        By: /s/ Donald Kushner
                                           -------------------------------------
                                           Name:  Donald Kushner
                                           Title: Co-CEO

                                        KLC/NEW CITY
                                        By its General Partner
                                        THE KUSHNER-LOCKE COMPANY

                                        By: /s/ Donald Kushner
                                           -------------------------------------
                                           Name:  Donald Kushner
                                           Title: Co-CEO

                                       3
<PAGE>   3
                                        LENDERS

Executed in                             THE CHASE MANHATTAN BANK (formerly
New York, New York                      known as Chemical Bank), individually
                                        and as Agent

                                        By: /s/ MARY ELLEN EGBERT
                                            ------------------------------------
                                            Name:  Mary Ellen Egbert
                                            Title: Managing Director

                                        NIB CAPITAL BANK N.V. (formerly known as
                                        De Nationale Investeringsbank N.V.)

                                        By:
                                            ------------------------------------
                                            Name:
                                            Title:

                                        By:
                                            ------------------------------------
                                            Name:
                                            Title:

                                        COMERICA BANK -- CALIFORNIA

                                        By:
                                            ------------------------------------
                                            Name:
                                            Title:

                                        FAR EAST NATIONAL BANK

                                        By:
                                            ------------------------------------
                                            Name:
                                            Title:

                                       4<PAGE>   1
                                                                    EXHIBIT 4.6

                 CONFIDENTIAL TREATMENT REQUESTED -- EDITED COPY

              AMENDMENT NO. 1 TO 6% CONVERTIBLE NOTE DUE 2005 AND
                      AMENDMENT NO. 2 TO OPTION AGREEMENT

                                                                    May 14, 2001

UBS AG, London Branch
c/o UBS Warburg LLC
677 Washington Blvd.
Stamford, CT 06901

Dear Sirs:

      We refer to the 6% Convertible Note Due 2005, dated as of December 7,
2000, of SciClone Pharmaceuticals, Inc. (the "Company") in the amount of
$4,000,000 (the "Convertible Note") and the Option Agreement between the Company
and you, dated October 26, 2000 (the "Option Agreement"). Capitalized terms not
defined herein have the meanings ascribed to them in the Convertible Note and
the Option Agreement.

      The Company and you hereby agree to amend the terms of the Convertible
Note and the Option Agreement as follows:

      (a)   For purposes of the Convertible Note, the term "Repurchase Price"
            shall have the meaning set forth in Annex A attached hereto.

      (b)   For purposes of any Zero Coupon Convertible Note Due 2005 issued
            pursuant to the Option Agreement, (the current form of which is
            attached to the Amendment No.1 to the Option Agreement dated
            December 19, 2000), the term "Repurchase Price" shall have the
            meaning set forth in Annex B attached hereto; and any such Zero
            Coupon Convertible Note shall reflect the amendment made hereby.

      In all respects not inconsistent with the terms and provisions of this
letter, each of the Convertible Note and the Option Agreement shall continue to
be in full force and effect in accordance with the terms and conditions thereof,
and is hereby ratified, adopted, approved and confirmed.

                                        1
<PAGE>   2

                CONFIDENTIAL TREATMENT REQUESTED -- EDITED COPY

      This letter agreement may be executed by the parties hereto in any number
of counterparts, each of which shall be deemed to be an original, but all such
respective counterparts shall together constitute one and the same instrument.

                                        Very truly yours,

                                        SciClone Pharmaceuticals, Inc.

                                        By:
                                           -------------------------------------
                                           Name: Donald R. Sellers
                                           Title: President and Chief Executive
                                                  Officer

Accepted as of the date hereof:

UBS AG, London Branch

By:
   -------------------------------------
   Name:
   Title:

By:
   -------------------------------------
   Name:
   Title:

                                       2

<PAGE>   3

                CONFIDENTIAL TREATMENT REQUESTED -- EDITED COPY

                                                                         ANNEX A

Repurchase Price means the sum of

(I) (a) in connection with any Change of Control involving a Stock Merger, 105%
of the principal amount of this Security to be repurchased pursuant to this
Section 3, and (b) in connection with any other Change of Control, the greater
of (x)120% of the principal amount of this Security to be repurchased pursuant
to this Section and (y) the amount determined pursuant to the following formula:

               [****]

(II) accrued and unpaid interest on this Security to the date of payment.

                                       3

<PAGE>   4

                CONFIDENTIAL TREATMENT REQUESTED -- EDITED COPY

                                                                         ANNEX B

Repurchase Price means the sum of

(I) (a) in connection with any Change of Control involving a Stock Merger, 105%
of the principal amount of this Security to be repurchased pursuant to this
Section 3, and (b) in connection with any other Change of Control, the greater
of (x)120% of the principal amount of this Security to be repurchased pursuant
to this Section and (y) the amount determined pursuant to the following formula:

               [****]

(II) accrued and unpaid interest on this Security to the date of payment.

                                       4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00027-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00027-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00027-of-00352.parquet"}]]